REG - Integrated Diag Hdgs - Holding(s) in Company
Yesterday 18:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260408:nRSH7094Za&default-theme=true
RNS Number : 7094Z Integrated Diagnostics Holdings PLC 08 April 2026
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
JE00BLKGSR75
Issuer Name
INTEGRATED DIAGNOSTICS HOLDINGS PLC
UK or Non-UK Issuer
Non-UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Actis LLP
City of registered office (if applicable)
London
Country of registered office (if applicable)
UK
4. Details of the shareholder
Name City of registered office Country of registered office
Actis IDH Limited Saint Peter Port Guernsey
5. Date on which the threshold was crossed or reached
31-Mar-2026
6. Date on which Issuer notified
08-Apr-2026
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 0.000000 0.000000 0.000000 0
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00B65TLW28 0 0 0.000000 000
Sub Total 8.A 0 0%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Actis LLP (chain 1) Actis GP LLP (as general partner of Actis Global 4 LP) 0.000000 0.000000 0.000000%
Actis LLP (chain 1) Actis Global 4 LP 0.000000 0.000000 0.000000%
Actis LLP (chain 1) Global 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 1) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 1) Actis IDH Limited (entity being disposed of) 21.670000 0.000000 21.670000%
Actis LLP (chain 2) Actis GP LLP (as general partner of Actis Global 4A LP) 0.000000 0.000000 0.000000%
Actis LLP (chain 2) Actis Global 4A LP 0.000000 0.000000 0.000000%
Actis LLP (chain 2) Global 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 2) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 2) Actis IDH Limited (entity being disposed of) 21.670000 0.000000 21.670000%
Actis LLP (chain 3) Actis GP LLP (as general partner of Actis Global 4C LP) 0.000000 0.000000 0.000000%
Actis LLP (chain 3) Actis Global 4C LP 0.000000 0.000000 0.000000%
Actis LLP (chain 3) Global 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 3) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 3) Actis IDH Limited 21.670000 0.000000 21.670000%
Actis LLP (chain 4) Actis Guernsey GP Limited (as General partner of Actis 4 Co-Investment Scheme 0.000000 0.000000 0.000000%
LP)
Actis LLP (chain 4) Actis 4 Co-Investment Scheme LP 0.000000 0.000000 0.000000%
Actis LLP (chain 4) Global 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 4) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 4) Actis IDH Limited (entity being disposed of) 21.670000 0.000000 21.670000%
Actis LLP (chain 5) Actis GP LLP (as general partner of Actis Africa 4 LP) 0.000000 0.000000 0.000000%
Actis LLP (chain 5) Actis Africa 4 LP 0.000000 0.000000 0.000000%
Actis LLP (chain 5) Africa 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 5) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 5) Actis IDH Limited (entity being disposed of) 21.670000 0.000000 21.670000%
Actis LLP (chain 6) Actis GP LLP (as general partner of Actis Africa 4A LP) 0.000000 0.000000 0.000000%
Actis LLP (chain 6) Actis Africa 4A LP 0.000000 0.000000 0.000000%
Actis LLP (chain 6) Africa 4 Sellco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 6) IDH Issuerco Limited 0.000000 0.000000 0.000000%
Actis LLP (chain 6) Actis IDH Limited 21.670000 0.000000 21.670000%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
As announced on 13 November 2025 by Integrated Diagnostics Holdings plc (the
"Company"), Actis GP LLP and Actis Guernsey GP Limited, each a subsidiary of
Actis LLP and which through funds under their management control shares
representing 21.67% of the Company (the "Actis Shareholding"), have agreed to
dispose, by way of an indirect share sale of Actis IDH Limited, of the entire
Actis Shareholding to a special purpose vehicle, the majority of which is
controlled by funds managed by Elliott Investment Management L.P. (the
"Transaction"). The Transaction, which at the time of the announcement was
conditional on the receipt of regulatory clearance (which was received on 31
March 2026, at which point the transfer became unconditional), will settle on
Thursday 9 April 2026.
12. Date of Completion
08-Apr-2026
13. Place Of Completion
London, United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLUWSNRNWUSRAR
Copyright 2019 Regulatory News Service, all rights reservedRecent news on Integrated Diagnostics Holdings
See all newsREG - Integrated Diag Hdgs - Holding(s) in Company
AnnouncementREG - Integrated Diag Hdgs - Holding(s) in Company
AnnouncementREG - Integrated Diag Hdgs - 3rd Quarter Results
AnnouncementREG - Integrated Diag Hdgs - Notice of Results
AnnouncementREG - Integrated Diag Hdgs - Half-year Report
Announcement